NORTHWEST BIOTHERAPEUTICS INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
NORTHWEST BIOTHERAPEUTICS INC (NWBO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 2.14 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-14
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 2.14M shares, a 756.00% increase year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 2.27M shares, a 355.00% increase from fiscal 2024.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 500.00K shares, a 97.53% decline from fiscal 2023.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 20.22M shares, a 152.59% increase from fiscal 2022.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 8.01M shares, a 779.67% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | 2.14M shares 10-Q · filed 2026-08-14 | 2.14M shares derived: sum of 3 quarters · filed 2026-08-14 | 2.14M shares derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | 2.14M shares 10-Q · filed 2026-05-15 | 2.14M shares derived: sum of 2 quarters · filed 2026-05-15 | 2.14M shares derived: sum of 3 quarters · filed 2026-05-15 | 4.17M shares derived: sum of 4 quarters · filed 2026-05-15 | |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | 0.00 shares derived: sum of 2 quarters · filed 2026-04-15 | 2.02M shares derived: sum of 3 quarters · filed 2026-04-15 | 2.27M shares 10-K · filed 2026-04-15 | |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 2.02M shares derived: sum of 2 quarters · filed 2025-11-14 | 2.27M shares 10-Q · filed 2025-11-14 | 2.27M shares derived: sum of 4 quarters · filed 2026-04-15 | |
| 2025-06-30 | 2.02M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 2.27M shares 10-Q · filed 2025-08-14 | 2.27M shares derived: sum of 3 quarters · filed 2026-04-15 | 2.27M shares derived: sum of 4 quarters · filed 2026-04-15 | |
| 2025-03-31 | 250.00K shares 10-Q · filed 2025-05-15 | 250.00K shares derived: sum of 2 quarters · filed 2026-04-15 | 250.00K shares derived: sum of 3 quarters · filed 2026-04-15 | 250.00K shares derived: sum of 4 quarters · filed 2026-04-15 | |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | 0.00 shares derived: sum of 2 quarters · filed 2026-04-15 | 0.00 shares derived: sum of 3 quarters · filed 2026-04-15 | 500.00K shares 10-K · filed 2026-04-15 | |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-12 | 500.00K shares 10-Q · filed 2024-11-12 | 500.00K shares derived: sum of 4 quarters · filed 2025-03-31 | |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | 500.00K shares 10-Q · filed 2024-08-09 | 500.00K shares derived: sum of 3 quarters · filed 2025-03-31 | ||
| 2024-03-31 | 500.00K shares 10-Q · filed 2024-05-10 | 500.00K shares derived: sum of 2 quarters · filed 2025-03-31 | |||
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 20.22M shares 10-K · filed 2025-03-31 | |||
| 2023-09-30 | 20.22M shares 10-Q · filed 2023-11-09 | ||||
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | 0.00 shares derived: sum of 2 quarters · filed 2024-03-05 | 8.00M shares derived: sum of 3 quarters · filed 2024-03-05 | 8.01M shares 10-K · filed 2024-03-05 | |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 8.00M shares derived: sum of 2 quarters · filed 2022-11-09 | 8.01M shares 10-Q · filed 2022-11-09 | 8.91M shares derived: sum of 4 quarters · filed 2024-03-05 | |
| 2022-06-30 | 8.00M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 8.01M shares 10-Q · filed 2022-08-09 | 8.91M shares derived: sum of 3 quarters · filed 2024-03-05 | 8.91M shares derived: sum of 4 quarters · filed 2024-03-05 | |
| 2022-03-31 | 20.00 shares 10-Q · filed 2022-05-10 | 909.11K shares derived: sum of 2 quarters · filed 2024-03-05 | 909.11K shares derived: sum of 3 quarters · filed 2024-03-05 | 909.84K shares derived: sum of 4 quarters · filed 2024-03-05 | |
| 2021-12-31 | 909.09K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | 909.09K shares derived: sum of 2 quarters · filed 2024-03-05 | 909.82K shares derived: sum of 3 quarters · filed 2024-03-05 | 910.00K shares 10-K · filed 2024-03-05 | 910.00 shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | 727.00 shares derived: sum of 2 quarters · filed 2021-11-15 | 910.00 shares 10-Q · filed 2021-11-15 | 208.32M shares derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | 727.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | 910.00 shares 10-Q · filed 2021-08-16 | 208.32M shares derived: sum of 3 quarters · filed 2023-02-28 | ||
| 2021-03-31 | 183.00 shares 10-Q · filed 2021-05-17 | 208.32M shares derived: sum of 2 quarters · filed 2023-02-28 | |||
| 2020-12-31 | 208.32M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 208.53M shares 10-K · filed 2023-02-28 | 208.53K shares 10-K · filed 2021-03-31 | ||
| 2020-09-30 | 203.60K shares 10-Q · filed 2021-01-15 | ||||
| 2019-12-31 | -1.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 4.50K shares 10-K · filed 2022-03-01 | 4.50M shares 10-K · filed 2020-03-16 | ||
| 2019-09-30 | 1.50M shares 10-Q · filed 2019-11-12 | ||||
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 2.97M shares derived: sum of 2 quarters · filed 2020-03-16 | 100.08M shares derived: sum of 3 quarters · filed 2020-03-16 | 100.09M shares 10-K · filed 2020-03-16 | |
| 2018-09-30 | 2.97M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-16 | 100.08M shares derived: sum of 2 quarters · filed 2018-11-16 | 100.09M shares 10-Q · filed 2018-11-16 | 111.42M shares derived: sum of 4 quarters · filed 2019-04-02 | |
| 2018-06-30 | 97.11M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | 97.12M shares 10-Q · filed 2018-08-14 | 108.45M shares derived: sum of 3 quarters · filed 2019-04-02 | 108.45M shares derived: sum of 4 quarters · filed 2019-04-02 | |
| 2018-03-31 | 11.34K shares 10-Q · filed 2018-05-16 | 11.34M shares derived: sum of 2 quarters · filed 2019-04-02 | 11.34M shares derived: sum of 3 quarters · filed 2019-04-02 | ||
| 2017-12-31 | 11.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-02 | 11.33M shares derived: sum of 2 quarters · filed 2019-04-02 | 11.34M shares 10-K · filed 2019-04-02 | 11.34K shares 10-K · filed 2018-04-17 | |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-20 | 11.34K shares 10-Q · filed 2017-11-20 | |||
| 2017-06-30 | 11.34K shares 10-Q · filed 2017-08-21 | ||||
| 2013-12-31 | 0.00 shares 10-K · filed 2014-04-01 | ||||
| 2012-12-31 | 0.00 shares 10-K · filed 2013-04-08 | ||||
| 2011-12-31 | 1.38M shares 10-K · filed 2013-04-08 |